Should You Invest in This Under-the-Radar Weight Loss Stock?

Getting in on the ground floor sounds like a great idea, but not if the building ends up crumbling. What is the hot, new, exciting, and fast-growing therapeutic area many drugmakers are trying to break into? If you guessed weight loss, you are right on the money. Therapies in this field, such as Eli Lilly's Zepbound and Novo Nordisk's Wegovy, are generating mouthwatering sales, so it's no wonder other companies are looking for a piece of the pie. It's not just prominent players in the industry, either: Many ...